According to their results, the analysis of imaging parameters such as maximum standardized uptake value, metabolic tumor volume, total lesion glycolysis, and textural features, including entropy, coarseness, and skewness, enables the prediction of pCR in both HER2-negative and HER2-positive patients [32]. This evidence concerns the gene ERBB2 and neoplasm.